Literature DB >> 33068096

Cotrimoxazole Induced Steven Johnson Syndrome: A Case Report.

Ayushma Acharya1, Shreedhar Prasad Acharya1, Tulsi Ram Bhattarai2.   

Abstract

Steven Johnson syndrome and toxic epidermal necrolysis are severe and rare adverse drug reactions usually caused by drugs like antiepileptics, penicillin and allopurinol and sometimes also due to infections, malignancy or idiopathic in some cases. Here we are reporting a case of a 50 years female who came with complaint of a burning sensation on the upper half of the body with atypical flat target lesion that later coalesced involving her face, chest and bilateral upper limbs. On examination, positive nikolsky sign and tenderness with <10% body surface area involvement was noticed. The diagnosis of cotrimoxazole induced Steven Johnson syndrome was made. Patient was shifted to ICU and given supportive care along with prophylactic teicoplanin, itraconazole and dexamethasone. The mechanism of eruptions in our patient was due to cotrimoxazole. Cotrimoxazole induced Steven Johnson syndrome is rare and the supportive management with broad spectrum antibiotic and the corticosteroid was enough to beat this life-threatening condition. Keywords: cotrimoxazole; pneumonia; Steven Johnson syndrome.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33068096      PMCID: PMC7580326          DOI: 10.31729/jnma.4999

Source DB:  PubMed          Journal:  JNMA J Nepal Med Assoc        ISSN: 0028-2715            Impact factor:   0.406


  9 in total

1.  SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.

Authors:  S Bastuji-Garin; N Fouchard; M Bertocchi; J C Roujeau; J Revuz; P Wolkenstein
Journal:  J Invest Dermatol       Date:  2000-08       Impact factor: 8.551

2.  Nevirapine and/or co-trimoxazole induced Stevens Johnson syndrome in HIV infected patient--a case report.

Authors:  Kaksha Patel; Ashwin Panchasara; Bhargav Purohit; C B Tripathi
Journal:  Curr Drug Saf       Date:  2013-02

3.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working Group.

Authors:  Emanual Maverakis; Elizabeth A Wang; Kanade Shinkai; Surakameth Mahasirimongkol; David J Margolis; Mark Avigan; Wen-Hung Chung; Jennifer Goldman; Lois La Grenade; Munir Pirmohamed; Neil H Shear; Wichittra Tassaeeyakul; Wolfram Hoetzenecker; Jettanong Klaewsongkram; Ticha Rerkpattanapipat; Wiparat Manuyakorn; Sally Usdin Yasuda; Victoria R Sharon; Andrea Sukhov; Robert Micheletti; Jeff Struewing; Lars E French; Michelle Y Cheng
Journal:  JAMA Dermatol       Date:  2017-06-01       Impact factor: 10.282

4.  Skin reactions to co-trimoxazole.

Authors:  E Schöpf
Journal:  Infection       Date:  1987       Impact factor: 3.553

Review 5.  Severe adverse cutaneous reactions to drugs.

Authors:  J C Roujeau; R S Stern
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

6.  Etiologic factors of the Stevens-Johnson syndrome.

Authors:  J Z Yetiv; J R Bianchine; J A Owen
Journal:  South Med J       Date:  1980-05       Impact factor: 0.954

Review 7.  Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis.

Authors:  Shuli Svetitsky; Leonard Leibovici; Mical Paul
Journal:  Antimicrob Agents Chemother       Date:  2009-07-13       Impact factor: 5.191

8.  Bullous esophageal lesions due to cotrimoxazole: an immune-mediated process?

Authors:  M Heer; J Altorfer; H R Burger; M Wälti
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

9.  Corrigendum to "The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China".

Authors:  Shang-Chen Yang; Sindy Hu; Sheng-Zheng Zhang; Jin-Wen Huang; Jing Zhang; Chao Ji; Bo Cheng
Journal:  J Immunol Res       Date:  2018-06-28       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.